Aether Q1: consolidated PAT +33% to ₹62.7 Cr on margin expansion, Site 5 onstream
PAT +33.45% YoY · revenue +27.49% · margins expanding
₹326.56 Cr
+27.49% YoY
₹62.75 Cr
+33.45% YoY
18.77%
+0.6pp YoY
₹4.77
Aether Industries opened FY27 with a clean, broad-based beat on its own margin guidance. Consolidated revenue rose to ₹326.6 Cr, up ~27.5% YoY and ~7% QoQ, while consolidated PAT climbed to ₹62.7 Cr — up 33.5% reported YoY (~28% adjusted for the ₹2.63 Cr exceptional insurance-premium loss that dented the year-ago base). With no exceptional item this quarter, the print is operationally clean. EPS was ₹4.77 versus ₹3.55 a year ago. There is no formal Street consensus for a company this size, so the relevant bar is management's own FY27 guidance from the Q4 concall — and this print clears it: operating margin expanded to ~31.5% (vs 30.5% a year ago and 26.7% last quarter), above the 29-30% EBITDA-margin guide, and net margin firmed to 19.2%, inside the 19-20% PAT-margin guide.
Q1 FY-2027 vs prior quarters
The margin bridge is favourable across the board: gross materials cost held while employee, depreciation and other expenses grew slower than the topline, and the sharp sequential OPM recovery from Q4's depressed 26.7% signals the earlier margin compression was transient. The key structural driver is capacity coming online — commercial production at Manufacturing Site 5 (GIDC Panoli) began June 26, 2026, and Site 3+ramp underpins the volume growth management flagged as its FY27 engine. This quarter confirms, rather than contradicts, the confident, very-optimistic long-term tone from the May concall.
The stock went into the print at ₹1,517.5, up 10.6% over the past month of trading.
Aether Industries provided a positive outlook with the successful commissioning of Site 3+and Phase 1 of Site 5 as key growth drivers for FY27. Management expects stable EBITDA margins between 29-30% and PAT margins around 19-20%. The company anticipates continued growth from existing CRAMS and CEM business models, w
— This quarter: beat
Basis matters here: consolidated PAT (+33.5% YoY) materially outpaced standalone PAT (₹48.3 Cr, +20.4% YoY), a divergence well beyond 3% — the gap is the wholly-owned subsidiary Aether Speciality Chemicals, which added ₹14.98 Cr of profit; readers comparing the standalone line elsewhere should note the subsidiary is doing real work. Separately, the long-running fire-insurance saga closed in-quarter: the insurer paid the ₹26.0 Cr balance settlement (₹22.5 Cr asset, ₹3.5 Cr financial loss), removing an overhang, though a smaller ₹7.0 Cr March-warehouse inventory claim remains under assessment. Alongside results the Board re-appointed the four promoter directors (Ashwin, Purnima, Rohan, Aman Desai) for five-year terms and designated six senior managerial personnel — continuity at the top as the capex cycle turns to output.
W1
Site 5 / Site 3+ramp: whether volume conversion sustains the ~27% revenue run-rate into H2 FY27
W2
Margin durability: holding OPM at/above the 29-30% guide once Site 5 fixed costs fully absorb
W3
CRAMS/CEM mix shift management targets toward >70% of revenue by FY30 — first read on share this quarter
Source in ₹ million; converted to ₹ Cr (÷10). No exceptional item this quarter; prior-year (Q1FY26) carried ₹2.63 Cr exceptional insurance-premium loss, so adjusted YoY differs. Insurance claim finalised in-quarter: ₹26.0 Cr balance settlement (₹22.5 Cr asset loss, ₹3.5 Cr FLOP). Single reportable segment. Wholly-owned subsidiary Aether Speciality Chemicals contributed ₹14.98 Cr PAT (consolidated>standalone). Standalone Q1FY26 PAT OCR-printed as '201.43mn' but arithmetic (531.50-130.07) gives 401.43mn = ₹40.14 Cr — used corrected value.
Informational and educational content only. Not investment advice.